Implementation Guide CH VACD
4.0.1 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Swiss AllergyIntolerance Codesystem - XML Representation

Active as of 2023-12-28

Raw xml | Download



<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="ch-vacd-allergyintolerance-cs"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>This case-sensitive code system <code>http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">allergyvaccinevarizella<a name="ch-vacd-allergyintolerance-cs-allergyvaccinevarizella"> </a></td><td>Adverse reaction to component of vaccine product containing varicella antigen</td></tr><tr><td style="white-space:nowrap">allergyvaccinehpv<a name="ch-vacd-allergyintolerance-cs-allergyvaccinehpv"> </a></td><td>Adverse reaction to component of vaccine product containing human papillomavirus antigen</td></tr><tr><td style="white-space:nowrap">allergyvaccineherpeszoster<a name="ch-vacd-allergyintolerance-cs-allergyvaccineherpeszoster"> </a></td><td>Adverse reaction to component of vaccine product containing Herpes zoster</td></tr><tr><td style="white-space:nowrap">allergyvaccinefsme<a name="ch-vacd-allergyintolerance-cs-allergyvaccinefsme"> </a></td><td>Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen</td></tr></table><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td></tr><tr><td>allergyvaccinevarizella</td><td>Unerwünschte Wirkung eines Varizellen-Impfstoffs</td><td>Effet indésirable du vaccin contre la varicelle</td><td>Adverse reaction to component of vaccine product containing varicella antigen</td></tr><tr><td>allergyvaccinehpv</td><td>Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs</td><td>Effet indésirable du vaccin contre le papillomavirus humain</td><td>Adverse reaction to component of vaccine product containing human papillomavirus antigen</td></tr><tr><td>allergyvaccineherpeszoster</td><td>Unerwünschte Wirkung eines Herpes-Zoster-Impfstoffs</td><td>Effet indésirable du vaccin contre le zona</td><td>Adverse reaction to component of vaccine product containing Herpes zoster</td></tr><tr><td>allergyvaccinefsme</td><td>Unerwünschte Wirkung eines FSME-Impfstoffs</td><td>Effet indésirable du vaccin contre la FSME</td><td>Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen</td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod">
    <valuePeriod>
      <start value="2021-01-24T00:00:00+01:00"/>
    </valuePeriod>
  </extension>
  <url
       value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs"/>
  <identifier>
    <use value="official"/>
    <system
            value="http://fhir.ch/ig/ch-vacd/cs/ch-vacd-allergyintolerance-cs"/>
    <value value="ch-vacd-allergyintolerance-cs"/>
  </identifier>
  <version value="4.0.1"/>
  <name value="SwissAllergyIntoleranceCodesystem"/>
  <title value="Swiss AllergyIntolerance Codesystem"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2023-12-28T11:10:40+01:00"/>
  <publisher value="HL7 Switzerland"/>
  <contact>
    <name value="HL7 Switzerland"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.hl7.ch/"/>
    </telecom>
  </contact>
  <description value="AllergyIntolerance codes in Switzerland."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="CHE"/>
    </coding>
  </jurisdiction>
  <copyright value="CC0-1.0"/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="4"/>
  <concept>
    <code value="allergyvaccinevarizella"/>
    <display
             value="Adverse reaction to component of vaccine product containing varicella antigen"/>
    <designation>
      <language value="de-CH"/>
      <value value="Unerwünschte Wirkung eines Varizellen-Impfstoffs"/>
    </designation>
    <designation>
      <language value="fr-CH"/>
      <value value="Effet indésirable du vaccin contre la varicelle"/>
    </designation>
    <designation>
      <language value="it-CH"/>
      <value
             value="Adverse reaction to component of vaccine product containing varicella antigen"/>
    </designation>
  </concept>
  <concept>
    <code value="allergyvaccinehpv"/>
    <display
             value="Adverse reaction to component of vaccine product containing human papillomavirus antigen"/>
    <designation>
      <language value="de-CH"/>
      <value
             value="Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs"/>
    </designation>
    <designation>
      <language value="fr-CH"/>
      <value
             value="Effet indésirable du vaccin contre le papillomavirus humain"/>
    </designation>
    <designation>
      <language value="it-CH"/>
      <value
             value="Adverse reaction to component of vaccine product containing human papillomavirus antigen"/>
    </designation>
  </concept>
  <concept>
    <code value="allergyvaccineherpeszoster"/>
    <display
             value="Adverse reaction to component of vaccine product containing Herpes zoster"/>
    <designation>
      <language value="de-CH"/>
      <value value="Unerwünschte Wirkung eines Herpes-Zoster-Impfstoffs"/>
    </designation>
    <designation>
      <language value="fr-CH"/>
      <value value="Effet indésirable du vaccin contre le zona"/>
    </designation>
    <designation>
      <language value="it-CH"/>
      <value
             value="Adverse reaction to component of vaccine product containing Herpes zoster"/>
    </designation>
  </concept>
  <concept>
    <code value="allergyvaccinefsme"/>
    <display
             value="Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen"/>
    <designation>
      <language value="de-CH"/>
      <value value="Unerwünschte Wirkung eines FSME-Impfstoffs"/>
    </designation>
    <designation>
      <language value="fr-CH"/>
      <value value="Effet indésirable du vaccin contre la FSME"/>
    </designation>
    <designation>
      <language value="it-CH"/>
      <value
             value="Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen"/>
    </designation>
  </concept>
</CodeSystem>